(Q78254940)
Statements
Use of factor-analyzed symptom dimensions to predict outcome with serotonin reuptake inhibitors and placebo in the treatment of obsessive-compulsive disorder (English)
Rauch SL
Manzo PA
Jenike MA
1 September 1999
scientific article published on 01 September 1999